Pfizer CEO Albert Bourla Acquires 22 Phantom Stock Units via Deferred Comp Plan

Insider Transaction Summary: Pfizer Inc. ($PFE)

Executive Overview

On September 16, 2026, Pfizer Inc. Chairman & CEO Albert Bourla reported the acquisition of 22 Phantom Stock Units under the company's Nonfunded Deferred Compensation and Supplemental Savings Plan (SSP). The transaction occurred on September 15, 2026, at a price of $27.55 per unit, representing a total transaction value of approximately $606.10.

Transaction Details

• Security: Phantom Stock Units SSP
• Transaction Code: A (Grant/Award/Plan Acquisition)
• Units Acquired: 22.0000
• Price Per Share: $27.55
• Total Transaction Value: $606.10
• Ownership Post-Transaction: 783,985.0000 units (Held Directly)

Market & Strategic Context

• Significance Level: Low
• Nature of Transaction: This transaction represents an automatic or routine credit of phantom stock units under Pfizer's deferred compensation and supplemental savings plan, settled in cash upon separation from service. Because of its routine programmatic nature and minimal nominal dollar amount, it does not provide an actionable directional signal regarding insider sentiment.